Phase I Trial of Viral Vector-Based Personalized Vaccination Elicits Robust Neoantigen-Specific Antitumor T-Cell Responses

 In Scientific publications

D’Alise et al, Clin Cancer Res 2024

Recent Posts
error: Content is protected !!!